96 related articles for article (PubMed ID: 23728394)
1. Early development of PAT-SM6 for the treatment of melanoma.
Hensel F; Eckstein M; Rosenwald A; Brändlein S
Melanoma Res; 2013 Aug; 23(4):264-75. PubMed ID: 23728394
[TBL] [Abstract][Full Text] [Related]
2. The anti-cancer IgM monoclonal antibody PAT-SM6 binds with high avidity to the unfolded protein response regulator GRP78.
Rosenes Z; Mulhern TD; Hatters DM; Ilag LL; Power BE; Hosking C; Hensel F; Howlett GJ; Mok YF
PLoS One; 2012; 7(9):e44927. PubMed ID: 23028685
[TBL] [Abstract][Full Text] [Related]
3. GRP78-directed immunotherapy in relapsed or refractory multiple myeloma - results from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6.
Rasche L; Duell J; Castro IC; Dubljevic V; Chatterjee M; Knop S; Hensel F; Rosenwald A; Einsele H; Topp MS; Brändlein S
Haematologica; 2015 Mar; 100(3):377-84. PubMed ID: 25637055
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous binding of the anti-cancer IgM monoclonal antibody PAT-SM6 to low density lipoproteins and GRP78.
Rosenes Z; Mok YF; Yang S; Griffin MD; Mulhern TD; Hatters DM; Hensel F; Howlett GJ
PLoS One; 2013; 8(4):e61239. PubMed ID: 23620733
[TBL] [Abstract][Full Text] [Related]
5. The natural human IgM antibody PAT-SM6 induces apoptosis in primary human multiple myeloma cells by targeting heat shock protein GRP78.
Rasche L; Duell J; Morgner C; Chatterjee M; Hensel F; Rosenwald A; Einsele H; Topp MS; Brändlein S
PLoS One; 2013; 8(5):e63414. PubMed ID: 23667612
[TBL] [Abstract][Full Text] [Related]
6. The in-vitro spheroid culture induces a more highly differentiated but tumorigenic population from melanoma cell lines.
Mo J; Sun B; Zhao X; Gu Q; Dong X; Liu Z; Ma Y; Zhao N; Liu Y; Chi J; Sun R
Melanoma Res; 2013 Aug; 23(4):254-63. PubMed ID: 23752306
[TBL] [Abstract][Full Text] [Related]
7. A GRP78-Directed Monoclonal Antibody Recaptures Response in Refractory Multiple Myeloma with Extramedullary Involvement.
Rasche L; Menoret E; Dubljevic V; Menu E; Vanderkerken K; Lapa C; Steinbrunn T; Chatterjee M; Knop S; Düll J; Greenwood DL; Hensel F; Rosenwald A; Einsele H; Brändlein S
Clin Cancer Res; 2016 Sep; 22(17):4341-9. PubMed ID: 27029491
[TBL] [Abstract][Full Text] [Related]
8. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
9. A murine monoclonal antibody directed against the carboxyl-terminal domain of GRP78 suppresses melanoma growth in mice.
de Ridder GG; Ray R; Pizzo SV
Melanoma Res; 2012 Jun; 22(3):225-35. PubMed ID: 22495669
[TBL] [Abstract][Full Text] [Related]
10. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.
Bolli M; Kocher T; Adamina M; Guller U; Dalquen P; Haas P; Mirlacher M; Gambazzi F; Harder F; Heberer M; Sauter G; Spagnoli GC
Ann Surg; 2002 Dec; 236(6):785-93; discussion 793. PubMed ID: 12454517
[TBL] [Abstract][Full Text] [Related]
11. mHFE7A, a newly identified monoclonal antibody to Fas, induces apoptosis in human melanoma cells in vitro and delays the growth of melanoma xenotransplants.
Hiramoto K; Inui M; Kamei T; Okumura K; Nakase M; Tagawa T
Oncol Rep; 2006 Feb; 15(2):409-15. PubMed ID: 16391862
[TBL] [Abstract][Full Text] [Related]
12. Human natural immunoglobulin M antibodies induce apoptosis of human neuroblastoma cells by binding to a Mr 260,000 antigen.
David K; Ollert MW; Vollmert C; Heiligtag S; Eickhoff B; Erttmann R; Bredehorst R; Vogel CW
Cancer Res; 1999 Aug; 59(15):3768-75. PubMed ID: 10446994
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a proapoptotic antiganglioside GM2 monoclonal antibody and evaluation of its therapeutic effect on melanoma and small cell lung carcinoma xenografts.
Retter MW; Johnson JC; Peckham DW; Bannink JE; Bangur CS; Dresser K; Cai F; Foy TM; Fanger NA; Fanger GR; Woda B; Rock KL
Cancer Res; 2005 Jul; 65(14):6425-34. PubMed ID: 16024647
[TBL] [Abstract][Full Text] [Related]
14. Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice.
El Khoury D; Destouches D; Lengagne R; Krust B; Hamma-Kourbali Y; Garcette M; Niro S; Kato M; Briand JP; Courty J; Hovanessian AG; Prévost-Blondel A
BMC Cancer; 2010 Jun; 10():325. PubMed ID: 20573279
[TBL] [Abstract][Full Text] [Related]
15. Human IgM monoclonal anti-GD2 antibody: reactivity to a human melanoma xenograft.
Katano M; Saxton RE; Tsuchida T; Irie RF
Jpn J Cancer Res; 1986 Jun; 77(6):584-94. PubMed ID: 3089993
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer cell proliferation in vitro is modulated by antibodies against glucose-regulated protein 78 isolated from patient serum.
Gonzalez-Gronow M; Cuchacovich M; Llanos C; Urzua C; Gawdi G; Pizzo SV
Cancer Res; 2006 Dec; 66(23):11424-31. PubMed ID: 17145889
[TBL] [Abstract][Full Text] [Related]
17. Basal caspase-3 activity promotes migration, invasion, and vasculogenic mimicry formation of melanoma cells.
Liu YR; Sun B; Zhao XL; Gu Q; Liu ZY; Dong XY; Che N; Mo J
Melanoma Res; 2013 Aug; 23(4):243-53. PubMed ID: 23695439
[TBL] [Abstract][Full Text] [Related]
18. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M
Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535
[TBL] [Abstract][Full Text] [Related]
19. [Establishment of a highly-metastatic model of human primary melanoma of the small intestine orthotopically transplanted in the small intestine of nude mice].
Tuo CW; Zhang N; Liu QZ; Yang B; Wang MY
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):885-90. PubMed ID: 19173986
[TBL] [Abstract][Full Text] [Related]
20. Taurolidine induces apoptosis of murine melanoma cells in vitro and in vivo by modulation of the Bcl-2 family proteins.
Sun BS; Wang JH; Liu LL; Gong SL; Redmond HP
J Surg Oncol; 2007 Sep; 96(3):241-8. PubMed ID: 17469118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
